The Medicare Payment Advisory Commission recommended Medicare continue its physician fee payment freeze despite ongoing financial pressure from the pandemic.
MedPAC, which advises Congress on Medicare payments to healthcare providers and health plans, said its analysis showed professional service payments are adequate and relief funds provided by Congress in the last two years should have covered the lost volume during the pandemic. The report also stated case volume and physician revenue are expected to rebound this year, and potentially reach higher rates as physicians address a backlog of cases.
So it's recommending that CMS continue physician fee schedule payments for 2023 as planned, which include a pay freeze.
|
|
Call for Abstracts & Poster Presentations
|
|
The deadline has been extended to MARCH 18
Take advantage of this opportunity and submit your proposal today!
|
|
Proposals accepted through
March 18th
|
A $50 submission fee is required upon completion of the form.
|
Questions can be directed to
Savannah Gold
at 270.554.9412 ext 4219 or
|
|
- Top 3 will present during the general session on the final day.
- Top 10 will present during the abstract breakout session.
-
Rapid review and publication in the Pain Physician journal will be extended to the Top 10 authors accepted for meeting presentations.
|
|
A new review article outlines a wide range of evidence-based psychological interventions for managing chronic pain, including supportive psychotherapy, cognitive behavioral therapy (CBT) and mind–body approaches.
“Our main focus in this article was to provide a thorough review and overview of the evidence of these psychological interventions, which are underutilized in routine clinical care, despite evidence of their effectiveness and widespread acknowledgment of their benefits among experts and clinicians,” senior author Robert Kerns, PhD, a professor of psychiatry, neurology and psychology at Yale School of Medicine, in New Haven, Conn., told Pain Medicine News (Psychol Sci Public Interest 2021;22[2]:52-95).
“Our message is clearly to try to increase awareness and knowledge of these approaches in the public and clinical settings and among healthcare organization leaders so they will work to improve their uptake in routine clinical care,” said Kerns, who also is a co-director of the Yale-based National Institutes of Health–Department of Defense–Department of Veterans Affairs Pain Management Collaboratory.
|
|
Your future self and your patients will thank you for putting self-care first
As physicians, self-care typically sits at the bottom of our priorities list. We have been socialized, trained, and habituated to put the patient first. While we've come to see this as virtuous, if we continue down this path we will find ourselves increasingly empty and tired. It is not only important to care for others, but equally as important to do so for ourselves, as this will enable us to continue to care for others without feeling depleted.
For women, it's not only social pressure that tells us we must be nurturers, providers, and peacekeepers for those around us at home or work. We put pressure on ourselves when we start believing using time for ourselves would be selfish or ignore the nagging need for self-care. Our plate is too full, our to-do list too long, and we're likely already running behind.
Much of our neglect of self-care -- and the suffering that results -- comes from the way our thoughts become "truths" we tell ourselves. Eventually, we cannot conceive an alternative. Our brain scans our external and internal environments to find "proof" to match the verity of the thought we are holding on to.
|
|
NEXT EXAM DATE:
Saturday, April 2, 10am CST
|
|
Beneficiaries seem to have adequate access to care, and few physicians are dropping out
Medicare payments to physicians don't need to be increased next year, the Medicare Payment Assessment Commission (MedPAC) said Tuesday in a report to Congress.
"Overall, access to clinician services for Medicare beneficiaries appears stable and comparable to that for privately insured individuals," the commissioners said in their 604-page report, one of two reports the commission is required to send Congress each year. Although the pandemic makes it difficult to assess beneficiaries' quality of care, "we expect volume and revenue to return to pre-pandemic levels (or higher) by 2023. Therefore, the commission does not see a reason to diverge from the current-law policy of no update for 2023."
At a press conference Tuesday, MedPage Today asked MedPAC executive director James Mathews, PhD, about whether the commission had considered the cumulative effect of several years without any payment increases for physicians. Mathews said that was "a very good question" and added that "some of our commissioners expressed concerns along these lines ... But our charge is to look at the data that we have and to inform our recommendations on the adequacy of Medicare payments."
|
|
Docs reimbursed for unnecessary treatments and illegally distributed 6.6 million opioid doses
A dozen physicians from Ohio and Michigan were sentenced to prison on Wednesday for their involvement in a $250 million healthcare fraud scheme that exploited patients suffering from opioid addiction, the Department of Justice (DOJ) announced.
The 12 individuals were among the 16 defendants who allegedly refused to distribute opioids to patients suffering from addiction unless they agreed to unnecessary back injections -- one of the highest reimbursable medical procedures, officials said. The physicians illegally distributed 6.6 million opioid doses.
The scheme unfolded between 2007 and 2018, at a multi-state network of pain clinics frequented by patients suffering from addiction who sought prescription drugs such as oxycodone. The doctors who worked at the clinics agreed to work just a few hours a week so that they could "stay under the radar" -- yet, they were some of the highest prescribers of oxycodone in the state of Michigan, officials said.
|
|
When I first started my social media page years ago, I never imagined the giant it would turn into today. I remember my colleagues making fun of me for blogging, and now my audience has grown into hundreds of thousands of followers between multiple platforms.
It has been said that physicians should not be on social media, but I beg to differ. Social media is exactly where physicians should be.
When I first started my social media channels and blog, it was to simply document my journey as a new mother in residency. I was fresh into an ob/gyn residency with a new baby after being told multiple times that I could never make the two work. My story resonated with many people, and I soon realized that my simple blogs would turn into so much more. Social media became a way of building my brand, providing medical information, and establishing a new patient base.
|
|
- ASIPP Members Only Site Information -
|
|
-
To log in for the first time you will need to click “forgot password” at the bottom of the login window.
- Check your email and then log in as directed.
-
If you have problems logging into your account, click here.
|
|
Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.
Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer-review and quality control as any other scholarly journal.
Interested in becoming a member of the PMCR Editorial Board?
Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.
For more information or to submit your articles, click here.
|
|
| CASE REPORT |
Roger Liu, DO, Marya Ghazzi, BS, Tomasz Chec, MD, Derek Ju, MD, Jeffrey Gehret, DO, Kristin Gustafson, DO, and Jeremy I. Simon, MD
Abstract
BACKGROUND: Minimally invasive lumbar decompression (MILD) is an interventional procedure for the treatment of patients with symptomatic lumbar spinal stenosis. Spinal cord injury after MILD has not yet been reported in literature.
CASE REPORT: We describe a case of a 95-year-old woman who underwent the MILD procedure at the L1-L2 level for symptomatic lumbar spinal stenosis. Following the procedure, the patient noticed lower extremity weakness and numbness, suprapubic numbness, groin pain, and urinary retention. Emergent magnetic resonance imaging of the lumbar spine exhibited new cord signal change at T12-L1. She subsequently underwent emergent L1-S1 decompression with gradual improvement of symptoms.
CONCLUSIONS: Direct trauma to the cord or increased pressure in a severely stenotic canal from injectate volume may have contributed to this patient’s injury. Consideration of the severity and location of stenosis is critical as these results may pose additional risk factors for injury with the MILD procedure.
KEY WORDS: MILD, spinal stenosis, spinal cord injury, interventional procedure
|
|
| RETROSPECTIVE REVIEW |
Omar S. Akbik, MD, Salah G. Aoun, MD, Owoicho Adogwa, MD, Carlos A. Bagley, MD, and Mazin Al Tamimi, MD
Abstract
Background: Spinal cord stimulation (SCS) is an accepted treatment for certain chronic pain syndromes. It is imperative that patients undergo a stimulation screening trial. For trial stimulation, typically patients undergo a percutaneous lead placement. Due to technical considerations, there exists a subset of patients who are not candidates for a percutaneous trial.
Objective: We present our experience with open paddle trial for spinal cord stimulation and review the characteristics of this patient population as well as the technique and efficacy of an open paddle lead trial for spinal cord stimulation.
Study design: Retrospective review.
Setting: University of Texas Southwestern Medical Center, Department of Neurosurgery.
Methods: We retrospectively identified 25 patients undergoing a paddle lead trial for spinal cord stimulation from September 2014 to September 2019.
Results: Twenty-five patients underwent a paddle lead trial for spinal cord stimulation. The average age was 61 with a range of 40 to 82 years; 19 were women and 6 were men. Twenty-two patients (88%) had failed back surgery syndrome (FBSS). Nine patients had attempted percutaneous trials that were unsuccessful, and 14 patients had extensive hardware and/or scar tissue, necessitating an open paddle trial. Twenty-three (92%) patients had a positive trial and went on to permanent implantation.
Limitations: The retrospective nature is a major limitation as well as loss to follow-up on several patients.
Conclusion: Patients, who have either failed or are deemed suboptimal for percutaneous trialing for spinal cord stimulation, should be considered for open paddle lead trialing. A multidisciplinary approach improves communication and helps to identify that subset of patients who otherwise may be left to pursue conservative measures only.
Keywords: failed back surgery syndrome; spinal cord stimulator; Paddle lead trial.
|
|
| NONRANDOMIZED CLINICAL TRIAL |
Jian-Xiong An, MD, PhD, Guo-Ping Wu, MD, Kun Niu, MD, You-Ping Wei, MD, Hui Liu, MD, Xin-You Gao, MD, Jian-Ping Wu, MD, Yong Wang, MD, Harald Renz, MD, and John P. Williams, MD
Abstract
Background: Osteonecrosis of the femoral head (ONFH) is a progressive and painful disorder due to impaired blood supply to the femoral head, yet little is known about the effect of ozone therapy in femoral head necrosis.
Objectives: We aimed to evaluate the clinical and radiographic outcomes of ozone therapy in the treatment of ONFH.
Study design: Nonrandomized clinical trial.
Settings: The study was conducted in a single-center, academic institution.
Methods: A total of 71 patients (107 hip joints) with Association Research Circulation Osseous (ARCO) stage-I, II, III, and IV ONFH were included and assigned to undergo either intraarticular O2-O3 mixture hip injections with ozonated autohemotherapy (ozone therapy group, n = 39, 58 hip joints) or protected weight bearing (control group, n = 32, 49 hip joints). The primary outcomes included the Visual Analog Scale (VAS) for pain intensity and Harris Hip Score (HHS) for hip function. The secondary outcomes included bone marrow edema examination, and conversion to total hip arthroplasty (THA).
Results: Ozone therapy effectively improves VAS for pain intensity and HHS during the follow-up period compared to the control group. Ozone therapy showed a significant resolution of bone marrow edema of the femoral head compared to the control group (P < 0.001). Thirteen of the 49 hips (26.53%) in the control group underwent THA, whereas only 6 hips (10.34%) in the ozone therapy group required THA during a 30-month follow-up (P = 0.041). The cumulative analysis revealed a low rate of conversion to THA in the ozone therapy group (logrank test; P = 0.022).
Limitations: The study is limited by a single treatment protocol in addition to the lack of a randomized design.
Conclusions: Ozone therapy was associated with significant pain relief, improvement in hip function, and bone marrow edema resolution that may delay the need for THA in patients affected by ONFH.Institutional Review Board (IRB) approval number: HK2018-10-28.Clinical trials registration number: ChiCTR1900023449.
Keywords: differential expressed genes; gene ontology; hip function; hip injection; ozone therapy; pain intensity; transcriptomics; Osteonecrosis of the femoral head.
|
|
Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices.
Norcal Mutual is A-Rated by AM best and is licensed in all 50 states. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary award-winning risk management CME activities, click here.
|
|
ASIPP® has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.
|
|
ASIPP® is now offering our members the benefit of a unique revenue cycle management/ billing service.
We have received a tremendous amount of interest in the ASIPP® billing and coding program.
Click here to learn more about the negotiated rate for practices and more!
|
|
|
up-to-date news related to you, your practice, and your patients!
|
|
|
|
|
|
|